Percutaneous CT-guided Radiofrequency Ablation for Lymph Node Oligometastases from Hepatocellular Carcinoma: A Propensity Score–matching Analysis

Authors:

Abstract
Percutaneous CT-guided radiofrequency ablation may be a safe and effective local-regional therapeutic option for lymph node oligometastases in select patients with hepatocellular carcinoma. Purpose To assess the effectiveness and safety of percutaneous computed tomography (CT)–guided radiofrequency ablation (RFA) for lymph node (LN) oligometastases from hepatocellular carcinoma (HCC). Materials and Methods This retrospective study was approved by the institutional ethics committee, and all patients provided written informed consent. From January 2004 to December 2013, 119 consecutive patients with HCC and LN oligometastases (115 men [mean age, 51.3 years; age range, 16–83 years] and four women [mean age, 38.2 years; age range, 23–47 years]) were included in this study. A matched cohort composed of 46 patients from each group was selected after adjustment with propensity score matching. The median follow-up time was 14.0 months in the RFA group and 13.8 months in the non-RFA group. The overall survival (OS), local control rate, and complications were evaluated. Survival curves were constructed with the Kaplan-Meier method and compared by using the log-rank test. Results Eighty-seven patients ...

This publication has 27 references indexed in Scilit: